GUANGZHOU, China, Nov. 19, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. ("Fangzhou” or the "Company”) (HKEX: 06086), a leading provider of AI?driven Internet healthcare solutions, announced a strategic partnership with Baiyunshan Pharmaceutical General Factory ("Baiyunshan Pharmaceutical”) at its 2026 Double 12 Partner Conference in Guangzhou, as the companies seek to expand AI-powered healthcare services and develop new digital marketing solutions. Fangzhou and Baiyunshan Pharmaceutical Launch AI-Powered Chronic Disease Management InitiativeThe conference brought together industry experts, pharmaceutical partners and healthcare professionals to explore opportunities in AI-powered digital marketing and full-lifecycle health management. Get the latest news delivered to your inbox Sign up…